262 related articles for article (PubMed ID: 31194233)
1. Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades.
McCrary HC; Babajanian E; Calquin M; Carpenter P; Casazza G; Naumer A; Greenberg S; Kohlmann W; Cannon R; Monroe MM; Hunt JP; Buchmann L
JAMA Otolaryngol Head Neck Surg; 2019 Jul; 145(7):641-646. PubMed ID: 31194233
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic patterns in patients with the head-and-neck paragangliomas associate with differential clinical characteristics.
Chen H; Zhu W; Li X; Xue L; Wang Z; Wu H
J Cancer Res Clin Oncol; 2017 Jun; 143(6):953-960. PubMed ID: 28255624
[TBL] [Abstract][Full Text] [Related]
3. Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.
Merlo A; de Quiros SB; Secades P; Zambrano I; Balbín M; Astudillo A; Scola B; Arístegui M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2194-200. PubMed ID: 22977270
[TBL] [Abstract][Full Text] [Related]
4. Genetic and clinical characteristics of head and neck paragangliomas in a Chinese population.
Zheng X; Wei S; Yu Y; Xia T; Zhao J; Gao S; Li Y; Gao M
Laryngoscope; 2012 Aug; 122(8):1761-6. PubMed ID: 22566157
[TBL] [Abstract][Full Text] [Related]
5. The phenotype of
Niemeijer ND; Rijken JA; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; Tops CMJ; van Berkel A; Timmers HJLM; Kunst HPM; Leemans CR; Bisschop PH; Dreijerink KMA; van Dooren MF; Bayley JP; Pereira AM; Jansen JC; Hes FJ; Hensen EF; Corssmit EPM
Eur J Endocrinol; 2017 Aug; 177(2):115-125. PubMed ID: 28490599
[TBL] [Abstract][Full Text] [Related]
6. Common genetic mutations in the start codon of the SDH subunit D gene among Chinese families with familial head and neck paragangliomas.
Wang CP; Chen TC; Chang YL; Ko JY; Yang TL; Lo FY; Hu YL; Chen PL; Wu CC; Lou PJ
Oral Oncol; 2012 Feb; 48(2):125-9. PubMed ID: 21945342
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
[TBL] [Abstract][Full Text] [Related]
8. Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine.
Richter S; Qiu B; Ghering M; Kunath C; Constantinescu G; Luths C; Pamporaki C; Bechmann N; Meuter L; Kwapiszewska A; Deutschbein T; Nölting S; Peitzsch M; Robledo M; Prejbisz A; Pacak K; Gudziol V; Timmers HJLM; Eisenhofer G
Endocr Relat Cancer; 2022 Mar; 29(4):213-224. PubMed ID: 35171114
[TBL] [Abstract][Full Text] [Related]
9. A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study.
de Vos B; Rijken JA; Adank MA; Hoksbergen AWJ; Bayley JP; Leemans CR; Hensen EF
Clin Otolaryngol; 2018 Jun; 43(3):841-845. PubMed ID: 29292578
[TBL] [Abstract][Full Text] [Related]
10. Malignant head/neck paragangliomas. Comparative study.
Mediouni A; Ammari S; Wassef M; Gimenez-Roqueplo AP; Laredo JD; Duet M; Tran Ba Huy P; Oker N
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Jun; 131(3):159-66. PubMed ID: 24239180
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
[TBL] [Abstract][Full Text] [Related]
12. Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management.
Hermsen MA; Sevilla MA; Llorente JL; Weiss MM; Grimbergen A; Allonca E; Garcia-Inclán C; Balbín M; Suárez C
Cell Oncol; 2010 Jan; 32(4):275-83. PubMed ID: 20208144
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic variability and risk of malignancy in SDHC-linked paragangliomas: lessons from three unrelated cases with an identical germline mutation (p.Arg133*).
Bickmann JK; Sollfrank S; Schad A; Musholt TJ; Springer E; Miederer M; Bartsch O; Papaspyrou K; Koutsimpelas D; Mann WJ; Weber MM; Lackner KJ; Rossmann H; Fottner C
J Clin Endocrinol Metab; 2014 Mar; 99(3):E489-96. PubMed ID: 24423348
[TBL] [Abstract][Full Text] [Related]
14. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
Piccini V; Rapizzi E; Bacca A; Di Trapani G; Pulli R; Giachè V; Zampetti B; Lucci-Cordisco E; Canu L; Corsini E; Faggiano A; Deiana L; Carrara D; Tantardini V; Mariotti S; Ambrosio MR; Zatelli MC; Parenti G; Colao A; Pratesi C; Bernini G; Ercolino T; Mannelli M
Endocr Relat Cancer; 2012 Apr; 19(2):149-55. PubMed ID: 22241717
[TBL] [Abstract][Full Text] [Related]
15. Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1α/miR-210 signaling pathway.
Merlo A; de Quirós SB; de Santa-María IS; Pitiot AS; Balbín M; Astudillo A; Scola B; Arístegui M; Quer M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1661-6. PubMed ID: 23902947
[TBL] [Abstract][Full Text] [Related]
16. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
17. Paraganglioma of the Head and Neck: A Review.
Sandow L; Thawani R; Kim MS; Heinrich MC
Endocr Pract; 2023 Feb; 29(2):141-147. PubMed ID: 36252779
[TBL] [Abstract][Full Text] [Related]
18. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing.
Brouwers FM; Eisenhofer G; Tao JJ; Kant JA; Adams KT; Linehan WM; Pacak K
J Clin Endocrinol Metab; 2006 Nov; 91(11):4505-9. PubMed ID: 16912137
[TBL] [Abstract][Full Text] [Related]
19. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
20. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
